Alma Sokolovic-Rasmussen

  • Content count

  • Joined

  • Last visited

Community Reputation

0 Neutral

About Alma Sokolovic-Rasmussen

  • Rank
    Advanced Member

Personal Information

  • Gender

Recent Profile Visitors

1,137 profile views
  2. until
    The Global Advisory Committee on Vaccine Safety (GACVS) was established in 1999 to respond promptly, efficiently, and with scientific rigour to vaccine safety issues of potential global importance. Report from the previous meetings can be found here:
  3. The Guardian, 9 July 2017 Babies born from the 1 August will be offered new ‘hexavalent’ jab in effort to clamp down on infections that cause cirrhosis and liver cancer. Read the full article:
  4. Immunisation Information Systems (IIS) are computerised confidential population based-systems containing individual-level information on vaccines received in a given area. They benefit individuals directly by ensuring vaccination according to the schedule and they provide information to vaccine providers and public health authorities responsible for the delivery and monitoring of an immunisation programme. In 2016, the European Centre for Disease Prevention and Control (ECDC) conducted a survey on the level of implementation and functionalities of IIS in 30 European Union/European Economic Area (EU/EEA) countries. See the report on Eurosurveillance, 27 April
  5. There is an overview of the events by country in the calendar. Feel free to post about your events here in the forum, or send us an email on and we can add your information to the calendar.
  6. Hi Gary, There is a short info on events in Belgium in the calendar, including DG SANTE workshop. Is that what you had in mind?
  7. Harvard University course: An in-depth look at the 1854 London cholera epidemic in Soho and its importance for the field of epidemiology.
  8. Immunization Specialist, UNICEF National immunization programme in Indonesia has high commitment from the government and reached around 80% routine immunization coverage in the past decade with basic antigens. The country also achieved the goal of Maternal and Neonatal Tetanus Elimination (MNTE) and maintained polio-free status. However, immunization coverage is still below the global target of 90% and administrative data shows a declining trend in 2014 and 2015. See the job vacancy Cold Chain Specialist, UNICEF To Support the immunization coverage and supply Chain improvement plan 2016-2017 Key Expected Results Updates on EVM Implementation Installation of central temperature management systems (CTMS) Temperature mapping of cold rooms completed See the job here Consultant, Data for Management of the Immunization Supply Chain, UNICEF The Data for Management Consultant will be based at UNICEF Supply Division for most of the length of the consultancy and will support the development of UNICEF's inputs to generating and using data for supply chain management, as well as monitoring and measuring the immunization supply chain. This will be done by (i) utilizing the available technical guidance pieces on supply chain data to produce written pieces with the purposes of advocacy, knowledge sharing... See the job vacancy
  9. Research article from Eurosurveillance, Volume 22, Issue 8, 23 February 2017 Systems for register-based monitoring of vaccine effectiveness (VE) against laboratory-confirmed influenza (LCI) in real time were set up in Stockholm County, Sweden, and in Finland, before the start of the 2016/17 influenza season, using population-based cohort studies [1,2]. In both locations, after an initial moderately high VE of about 50%, a rapid and sharp 20% decline in VE was observed. In addition, reports from hospitals and outpatient clinics indicated that a majority of patients with influenza-like illness (ILI) and severe acute respiratory infection (SARI) were elderly people, i.e. those 65 years and above, and that many of them had been vaccinated with the seasonal influenza vaccine (SIV). We therefore wanted to calculate early and mid-season estimates of influenza VE and compare the results between the two populations. The aim was to evaluate VE for LCI in persons 65 years and above, an age group eligible for free SIV.
  10. Thanks for the tip on the event Gary!
  11. In a revised position paper on tetanus toxoid (TT) vaccines published in today’s edition of the Weekly Epidemiological Record, WHO provided updated guidance on vaccination schedules for primary and booster vaccine doses, according to age and population group. All children worldwide should be immunized against tetanus. Every country should seek to achieve early and timely infant vaccination. Other tetanus prevention efforts are also needed including individual and community education on clean wound care and the importance of following standard surgical protocols in accordance with WHO guidelines. Read the updated position paper
  12. Article in Euro News: Measles is on the rise in parts of Europe amid a trend of high scepticism towards vaccines in some rich countries, research shows. According to data collected by research group Civio in partnership with Euronews, Germany alone (2,464) had four times as many incidents of the disease as the entire American continent (611) in 2015. Italy and the UK both suffered fresh outbreaks of the disease in 2016, official data shows. Europe is a world leader when it comes to lacking confidence in vaccines. Read the full article:
  13. Vaccines are an essential weapon in fighting disease outbreaks. But how does the time taken to develop vaccines compare to the speed and frequency of outbreaks? And how can we do it better? A feature by Mosaicscience, lets you navigate by disease and see possible scenarios for how many lives can be saved. See it here
  14. until
    The International Association of Immunization Managers (IAIM), a program of the Sabin Vaccine Institute, will host immunization professionals from the Americas and Europe to discuss strategies and challenges facing immunization programs. The theme of this meeting will be Vaccine Acceptance and Demand. This has been a topic of growing interest internationally, and is particularly relevant for the Americas and Europe. Presentations will explore different facets of this issue, including the factors influencing why some populations hesitate or refuse to accept vaccines; programmatic methods of improving vaccine acceptance and demand; research findings documenting the outcomes of such programmatic interventions and illuminating successful approaches; and tools to help countries think through their approach to these issues. More information can be found on the IAIM website here.